|
|
Navidea Biopharmaceuticals, Inc.
|
 |
||||||||
|
 |
  |
 |
|
|
||
 |
 |
 
|
return to message board, top of board |
Re: 50th Participant Enrolled in Phase 3 RA trialKudos to the science team. They are not the problem....funding constraints are not their business. By now, we should be fully funded through P3 like JL professed numerous times more than a year ago. So again, I say....the market is not impressed by the glacier pace of progress....and thus we sit at 0.20 something. |
||||||||||||
|
|
return to message board, top of board |
| Msg # | Subject | Author | Recs | Date Posted |
| 38583 | Re: 50th Participant Enrolled in Phase 3 RA trial | moneyonomics | 0 | 11/28/2022 7:40:45 PM |
| 38586 | Re: 50th Participant Enrolled in Phase 3 RA trial | LVoptimist | 0 | 11/29/2022 12:07:35 PM |
